Palvella Therapeutics (PVLA) Current Deferred Revenue (2013 - 2023)
Palvella Therapeutics (PVLA) reported Current Deferred Revenue of $994,000 for Q3 2023, down 94.6% from $18.5 million a year earlier and down 94.4% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Current Deferred Revenue (2013 - 2023) Analysis & Trends
At the end of FY2022, Palvella Therapeutics posted Current Deferred Revenue of $20.82 million, down 17.1% from FY2021.
- Current Deferred Revenue has a five-year compound annual growth rate of -10.9% (FY2017 to FY2022).
- By year, Current Deferred Revenue came in at $25.12 million in FY2021 (+98.9%), $12.63 million in FY2020 (+12.2%), $11.26 million in FY2019 (-68.4%) and $35.61 million in FY2018 (-4.1%).
- The Q3 2023 figure ranks as the lowest quarterly Current Deferred Revenue since Q4 2013.
- Year over year, Current Deferred Revenue gained in three of the last eight quarters, with an average decline of 3.4%.
- The high point for year-over-year Current Deferred Revenue in five years was Q2 2021 (growth of 222.8%); the low point was Q3 2023 (a decline of 94.6%).
- Per Business Quant data, the three quarters before Q3 2023 came in at $17.68 million (Q2 2023), $26.69 million (Q1 2023) and $20.82 million (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Palvella Therapeutics | 1.82 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 994,000.00 |
| Jun 30, 2023 | 17.68 Mn |
| Mar 31, 2023 | 26.69 Mn |
| Dec 31, 2022 | 20.82 Mn |
| Sep 30, 2022 | 18.50 Mn |
| Jun 30, 2022 | 22.86 Mn |
| Mar 31, 2022 | 20.91 Mn |
| Dec 31, 2021 | 25.12 Mn |
| Sep 30, 2021 | 26.45 Mn |
| Jun 30, 2021 | 25.54 Mn |
| Mar 31, 2021 | 17.24 Mn |
| Dec 31, 2020 | 12.63 Mn |
| Sep 30, 2020 | 10.05 Mn |
| Jun 30, 2020 | 7.91 Mn |
| Mar 31, 2020 | 10.04 Mn |
| Dec 31, 2019 | 11.26 Mn |
| Sep 30, 2019 | 27.24 Mn |
| Jun 30, 2019 | 28.41 Mn |
| Mar 31, 2019 | 28.18 Mn |
| Dec 31, 2018 | 35.61 Mn |
API Access
Palvella Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();